# Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma

> **NCT05894018** · PHASE2 · RECRUITING · sponsor: **Fujun Zhang** · enrollment: 32 (estimated)

## Conditions studied

- Sarcoma,Soft Tissue
- Brachytherapy
- Poly(ADP-ribose) Polymerase Inhibitors

## Interventions

- **DRUG:** Fluzoparib
- **PROCEDURE:** Radioactive particle implantation

## Key facts

- **NCT ID:** NCT05894018
- **Lead sponsor:** Fujun Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-29
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894018, "Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05894018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*